Mammalian cells have a remarkable diverse repertoire of response to genotoxic stress that damage DNA. Cellular responses to DNA damaging agents will initially exhibit gene induction, which is regulated by complex mechanism(s) and probably involves multiple signaling pathways. In this paper, we demonstrate that induction of ATF3 protein, a member of the ATF/CREB family of transcription factors, by ionizing radiation (IR) requires normal cellular p53 function. In contrast, induction of ATF3 after UV radiation (UV) or Methyl methanesulphonate (MMS) is independent of p53 status. Induction of ATF3 by DNA damage is rapid, transient, and through a transcriptional mechanism. The ATF3 promoter is induced by UV and MMS, but not by IR. In addition, ATF3 promoter can be activated by MEKK1, an upstream activator of the ERK and JNK kinase pathway, but not induced following p53 expression. Those results indicate that regulation of ATF3 induction after DNA damage utilizes both the p53-dependent andindependent pathways, and may also involve MAP kinase signaling pathways. Using the tetracyclineinducible system (tet-off), we have found that overexpression of ATF3 protein moderately suppresses cell growth. Interestingly, over-expression of ATF3 protein is able to slow down progression of cells from G1 to S phase, indicating that ATF3 protein might play a negative role in the control of cell cycle progression.
Introduction
Mammalian cells have evolved complex responses to genetoxic stresses and these cellular responses serve a protective function. After DNA damage, several biological events, such as cell cycle growth arrest, apoptosis, and DNA repair are thought to be critical in maintaining genomic fidelity and chromatin structure after exposure of cells to DNA agents, including ionizing radiation (IR), UV radiation (UV) and alkylating agents. Those events serve to prevent the propagation of DNA damage to daughter cells and thus limit the generation and stable transmission of mutations. Obviously, abrogation of these biological events may result in genomic instability and malignant cell transformation (Hartwell and Kastan, 1994; Kastan et al., 1991 Kastan et al., , 1992 Rajanbabu and Patarca, 1999; Schmutte and Fishel, 1999; White, 1996) .
The responses to DNA damage can be distinctive according to different types of DNA-damaging agents and influenced by tumor suppressor gene p53. In some cases, cellular response to DNA damage requires normal p53 status, but in other cases it is independent of p53. In addition, different cell types exposed to DNA damage can undergo either growth arrest or apoptosis, which may occur through p53-dependent as well as -independent pathways (Evan and Littlewood, 1998; Kastan et al., 1992; Miyashita and Reed, 1995; Vaux and Strasser, 1996; White, 1996; Zhan et al., 1994b) . However, the understanding of the molecular pathways that mediate the cellular response to DNA damage is currently limited. As expected from the involvement of p53 in this response, downstream effector genes of p53 are well involved. These p53 targets include p21 waf1/cip1 , a potent inhibitor of cyclindependent kinases (el-Deiry et al., 1993 (el-Deiry et al., , 1994 , GADD45, a growth-arrest and DNA damage-inducible gene (Kastan et al., 1992; Zhan et al., 1994a) , and BAX, a Bcl-2 family member (Miyashita and Reed, 1995; Zhan et al., 1994b) . It has been documented that GADD45 and p21 waf1/cip1 play roles in cell cycle growth arrest (Harper et al., 1993; Wang et al., 1999; Xiong et al., 1993; Zhan et al., 1999) , and BAX plays an important role in induction of apoptosis (Korsmeyer et al., 1993; Yin et al., 1995) .
To a great extent, cellular responses after DNA damage will initially include the induction of the stressinducible genes. Many of those stress-inducible genes are transcription factors. Activation of transcription factors by DNA damage directly enhances/represses the transcription of their targeted genes, which can exert biological functions in cellular responses. Several transcription factors, such as p53, c-Myc, AP-1 (c-jun and c-fos) and Oct-1, have been characterized to play important roles in the control of cell cycle checkpoints, apoptosis and signaling transduction pathways (Amundson et al., 1998; Haas and Kaina, 1995; Hollander and Fornace, 1989; Jin et al., 2001; Kastan et al., 1992; Kumari and Alvarez-Gonzalez, 2000; Rupnow et al., 1998; Tong et al., 2001; Yu et al., 2002; Zhan et al., 1994a; Zhao et al., 2000) .
Activating transcription factor 3 (ATF3) is a member of the ATF/CREB family of transcription factors (Liang et al., 1996) . It contains the basic region and leucine zipper (bZIP) motif characteristic of the bZIP superfamily of transcription factors, which includes members of the CCAAT/enhancer-binding protein (C/ EBP) family, the Jun/Fos (AP-1) family and ATF/ CREB family (Allan et al., 2001; Drysdale et al., 1996; Hai and Hartman, 2001 ). ATF3 protein is expressed at a low levels in normal and quiescent cells, but can be rapidly and highly induced in response to multiple and diverse extracellular signals including growth factors, cytokines and some genotoxic stress agents Hai and Hartman, 2001; Hai et al., 1999) . However, little is known about ATF3 physiological function although several lines of evidence indicate that ATF3 might be involved in homeostasis, wound healing, cell adhesion, cancer cell invasion, apoptosis and signaling pathways (Allen-Jennings et al., 2001; Chen et al., 1996; Hai and Hartman, 2001; Ishiguro and Nagawa, 2000; Mashima et al., 2001; Wolfgang et al., 1997 Wolfgang et al., , 2000 . Recently, ATF3 was reported to interact with p53 and antagonize its trans-activations of the MMP2 gene, which is involved in the process of promoting tumor metastases (Yan et al., 2002) . Here, we report that the pattern of IR response of ATF3 differs from its response to UV radiation or MMS. Only IR induction of ATF3 correlates with normal cellular p53 function. The ATF3 induction by damaging agents is rapid and transient. The ATF3 promoter can be strongly induced by UV or MMS, but not by IR. In addition, the ATF3 promoter is activated following expression of MEKK1, an upstream activator of JNK and ERK pathways, but not responsive to p53 expression. Importantly, overexpression of ATF3 protein via a tetracycline-inducible system suppresses cell growth and slow down the transition of cell from G1 to S phase. Those results suggest that ATF3 protein might play a negative role in cell cycle progression.
Results
Induction of ATF3 protein after DNA damage is regulated by both the p53-dependent and -independent pathways
Several lines of evidence have demonstrated that ATF3 mRNA is induced following genotoxic stress (Hai et al., 1999) . We then investigated ATF3 proteins induction after different types of DNA damaging agents. A group of human cells with known p53 phenotype were exposed to Methyl Methanesulphonate (MMS), UV radiation (UV) or ionizing radiation (IR). Cells were collected at 8 h after treatment and analysed for ATF3 protein expression. As shown in Figure 1 and Table 1 , all cell lines treated with MMS and UV, that are both DNA-base damaging agents, exhibited high induction of ATF3 protein, with a range up to 16-fold. Obviously, the induction of ATF3 protein by UV and MMS does not require normal cellular function of tumor suppressor p53, because the induction was observed in the cells with inactivated p53 function, such as H1299, where p53 is deleted, Hela that contains HPV-E6, an inhibitor of p53. However, induction of ATF3 protein by IR, which mainly produces DNA strand break, appears to correlate with normal p53 status. In cells with normal p53 function, the levels of ATF3 protein increased substantially. In contrast, cells with absent p53 (H1299, HL-60 and HCT116 p537/7) or inactivated p53 (Hela and RKOE6) failed to show evident induction of ATF3 protein after IR treatment.
Further analysis was carried out to compare the induction of ATF3 protein at different doses of Figure 1 Induction of ATF3 protein following DNA damaging agents in human cells with known p53 status. (a) Human cell lines with known p53 status were exposed to Methyl-Methane sulphonate (MMS, 100 mg/ml), UV radiation (UV, 10 Jm 72 ) and ionizing radiation (IR, 20 Gy). Cells were harvested at 8 h posttreatment and cellular proteins were prepared as described in Methods and materials. One hundred mg of total cell protein was loaded onto 12% SDS polyacrylamide gels. Following electrophoresis, the proteins were transferred to Immobilon membranes. Membranes were then blocked for 30 min in 5% milk at room temperature. Measurement of ATF3 protein was performed with anti-Oct-1 antibody (Santa Cruz Biotech, CA, USA). Immunoreaction was revealed using chemiluminescence detection procedure. As a loading control, detection of actin protein was included. Only visualized bands are shown; their estimated sizes were 28 kDa for ATF3 and 43 kDa for actin. All experiments were performed at least three times. The results of the representative experiment were shown in this Figure   ATF3 plays a negative role in cell cycle progression F Fan et al DNA damaging agents. Similarly, the magnitude of ATF3 protein induction by all three DNA-damaging agents was approximately proportional to dose in RKO cells. As shown in Figure 2a , IR-induction of ATF3 protein reached maximal level with 20 Gy. In the case of DNA-base damaging agents, maximal induction of ATF3 protein was generated by 100 mg/ ml of MMS and 20 Jm 72 of UV. Next, the duration of ATF3 induction after DNA damage was measured in RKO cells. In Figure 2b , induction of ATF3 protein by either IR (20 Gy) or UV (10 Jm 72 ) was rapid and transient. Evident induction of ATF3 by UV or IR occurred within 1 h post-treatment. The induction level of ATF3 protein peaked at 8 h after cells were treated with IR or UV. In contrast to IRinduction that sharply decreased by 10 h even with this very high g-dose, UV-induction of ATF3 remained a longer time. However, the induction of ATF3 protein after DNA damage was seen to return to the normal basal level between 24 h (IR) and 36 h (UV). These results demonstrated that ATF3 induction by DNA damage is a transient response to genotoxic stress.
Transcriptional mechanism is involved in induction of ATF3 protein after DNA damage
We next performed experiments to determine the mechanism by which DNA damaging agents activate expression of ATF3 protein. As shown in Figure 3a , the levels of ATF3 transcripts after DNA damage were measured using RT -PCR analysis. Four human cell lines with known p53 phenotype were exposed to MMS at a concentration of 100 mg/ml and collected at 4 or 8 h for RT -PCR analysis. Clearly, mRNA levels of ATF3 after MMS treatment elevated in all cell lines tested regardless of p53 status. To ensure that equal amounts of mRNA used for RT -PCR and equal amounts of PCR products were loaded, b-actin was included in the experiments and showed unchanged levels after DNA damage. In addition, we analysed the mRNA level of ATF3 after DNA damage in the presence of cycloheximide (25 mg/ml), a potent inhibitor of protein synthesis, and found that We next analysed ATF3 protein induction by DNA damage in the presence of actinomycin D, an inhibitor of RNA synthesis. In this experiments, actinomycin D was added at a concentration of 1 mg/ml in cell culture, where cells were exposed to MMS. In Figure 3b , ATF3 protein was shown to be highly induced by MMS at different time points (4, 8 and 12 h). Actinomycin D alone had little effect on ATF3 protein expression. However, addition of actinomycin D in cell culture significantly abolished induction of ATF3 protein after DNA damage. Therefore, these results indicate that induction of ATF3 protein is at least in part mediated through a transcriptional mechanism. We also examined sub-cellular localization of induced ATF3 protein in both HCT116 and HCT116 p537/7 cells. However, induced ATF3 protein was found mostly to remain at the nucleus in both cell lines, suggesting the p53 status does not alter ATF3 protein subcellular localization (results not shown).
ATF3 promoter is activated by UV and MMS, but not IR and the MAP kinase pathway is involved in activation of the ATF3 promoter As described above, induction of ATF3 protein after DNA damaging involves a transcriptional mechanism. We next investigated induction of the ATF3 promoter after DNA damaging agents (Figure 4) . To do this, pATF3-CAT, a reporter construct driven by ATF3 promoter from 71850 to 34, was employed in the experiment. The ATF3 promoter reporter construct was transiently transfected into HCT116 cells and followed by treatment with UV (10 Jm 72 ), MMS (100 mg/ml) or IR (10 Gy). As measured by CAT activity (see Materials and methods), pATF3-CAT was strongly activated by UV and MMS and CAT activity increased more than eightfold. Surprisingly, IR treatment did not activate the ATF3 promoter. These results strongly suggest that there are differential molecular pathways involved in ATF3 activation after exposure to different types of DNA damaging agents. In addition, pATF3 was co-introduced with wt p53 or mutant p53 expression vectors into HCT116 cells. However, p53 protein appeared to have no activating effect on the ATF3 promoter, indicating that p53-regulatory elements are not located at the promoter region of ATF3 although p53 is required for the IRinduction of ATF3 protein. Interestingly, MEKK1, an upstream activator of the ERK and JNK kinase pathway, was shown to strongly activate the ATF3 promoter reporter construct and the CAT activity was elevated as high as 14-fold, indicating that MAP kinase signaling pathways are involved in the responsiveness of the ATF3 promoter to genotoxic stress. Moreover, pATF3-CAT was shown to be activated by BRCA1, a breast cancer susceptibility gene that has transcriptional properties, after co-introduction with BRCA1 expression vector into HCT116 cells. This observation is in agreement with other's report, where the ATF3 mRNA was induced by BRCA1 when using microarray analytic approach (Harkin et al., 1999) .
Inducible expression of ATF3 moderately suppresses cell growth and slows down cell cycle progression
To investigate biological function of ATF3 protein, we established tetracycline-regulated ATF3-inducible cell lines in Hela cells, where high expression of ATF3 protein is controlled by a tetracycline-inducible system. In the present study, Hela-ATF3-1 (Hela-ATF3 inducible cell line) was employed. As shown in Figure  5a , Hela-ATF3-1 cells exhibited a low level of the endogenous ATF3 protein. Following withdrawal of tetracycline, ATF3 protein was greatly induced and presented more than fivefold induction in those cells. Next, effect of ATF3 protein on growth suppression was examined in this cell line. To perform the experiment, 500, 1000 or 2000 cells were seeded and grown in DMEM medium in 100 cm dishes 16 h prior to tetracycline withdrawal. After removing tetracycline, cells continued to grow for 14 days and then were Figure 3 Induction of ATF3 protein is mediated through transcriptional mechanism. (a) 0.5 mg of total RNA from cells treated with MMS was used in 20 ml of RT mixture containing: 4 ml of 25 mM MgCl 2 , 2 ml of 106PCR Buffer, 2 ml of DEPC water, 8 ml of dNTP, 1 ml of RNase Inhibitor (20 U/ml), 1 ml of Random Hexamers (50 mM), and 1 ml of MuLV Reverse Transcriptase (50 U/ml). After reverse transcription, 10 ml of cDNA products were added to 40 ml of PCR mixture containing: 2 ml of 25 mM MgCl 2 , 4 ml of 106PCR Buffer, 3 ml of dNTP mix, 0.5 ml of Taq DNA Polymerase and 2 ml of 1 : 1 primer mix (30 mM each of upstream and downstream primer). The mixture was subjected to DNA amplification using GeneAmp PCR System 9600. Finally, 30 ml of PCR products were loaded on 1% agarose gel for analysis. (b) Human colorectal carcinoma RKO cells were treated with MMS (100 mg/ml). Meanwhile, Actinomycin D was added to the cell culture medium at a final concentration of 1 mg/ml. Cells were collected at the indicated time for analysis of ATF3 protein expression. Each experiment was repeated more than three times and only the representative one was shown in this Figure   ATF3 plays a negative role in cell cycle progression F Fan et al fixed, and scored for colonies containing more than 50 cells. In Figure 5b , induced ATF3 expression in Hela-ATF3-1 cells moderately suppressed cell growth. Colony formation was reduced by 50% following induction of ATF3 protein, indicating that ATF3 protein might play a negative role in cell growth. In addition, we examined the effect of ATF3 protein on cell killing by several therapeutic agents and the results were also shown in Figure 5b . Upon withdrawal of tetracycline, cells were treated with IR (1 Gy), cisplatinum (0.4 mM) or etopside (0.4 mM) and the colony formation assay was conducted as described above. At the doses used, all three treatments generated about 50% growth suppression. However, in the presence of inducible ATF3 protein, growth inhibition by those reagents was substantially enhanced, indicating that ATF3 protein is able to generate additive effect for cell killing by those therapeutic agents. In addition, the negative effect of ATF3 on cell growth was further confirmed by measuring cell proliferation (Figure 3c ).
We further examined the effect of ATF3 protein expression on cell cycle progression using flow cytometric analysis. ATF3-inducible cells (Hela-ATF3-1) were placed and grown in DMEM medium containing tetracycline. Following withdrawal of tetracycline, ATF3-inducible cells (Hela-ATF3-1) were collected for FACS analysis at the indicated time points. In these experiments, nocodazol, a microtubule inhibitor, was included to prevent cells from cycling into a second G1 phase. The results were summarized in Table 2 . During the period of 0 -6 h, both Tet-off cells (expressing high levels of ATF3 protein after removing tetracycline) and Tet-on cells (cells grown in the presence of tetracycline) displayed similar fractions in G1, S and G2/M phases. However, starting from 8 h after withdrawal of tetracycline, the Tet-off cell exhibited a slow transition from G1 to S phase compared to Tet-on cells, as a bigger population was seen to remain at the G1 phase in Tet-off cells. These results suggest that ATF3 might be able to slow down progression of cells from G1 to S phase.
Discussion
The data presented in this paper demonstrate that ATF3, a member of the ATF/CREB family of transcription factors, is induced following different types of DNA damaging agents, including IR, UV and MMS. Interestingly, IR-induction of ATF3 depends on normal cellular p53 status since this protein is not induced by IR in cells with deleted or mutated p53. In Figure 4 Induction of ATF3 promoter following DNA damage and expression of p53, BRCA1 and MEKK1. Four mg of the ATF3 promoter CAT reporter constructs (pATF3-CAT) were contransfected with 4 mg of indicated expression vectors (GFP, p53, mutant p53 BRCA1 or MEKK1) into HCT116 cells via the calcium phosphate method. Forty-eight hours later, cells were collected for the CAT assay (see Materials and methods). In some cases, cells transfected with ATF3 promoter CAT reporter plasmid were treated by IR (20 Gy), MMS (100 mg/ml) or UV (10 Jm 72 ) Figure 5 Cell growth suppression following expression of ATF3 protein.
(a) Hela-ATF3-inducible cell line was established as described in Materials and methods. Cells were placed in 100 mm dishes at a density of 4610 5 and grown in DMEM medium containing tetracycline at a concentration of 2 mg/ml. After withdrawal of tetracycline, cells were collected at the indicated time points for preparation of cellular protein. One hundred mg of whole cell protein was used for immunoblotting analysis with anti-ATF3 antibody. As a loading control, anti actin antibody was included. (b) Hela-ATF3-1 inducible cells were seeded in 100 cm dishes and grown in DMEM medium containing 2 mg/ ml tetracycline for 16 h. Upon the withdrawal of tetracycline, cells were treated with IR (1 Gy). Cis-platinum (0.4 mM) or etopside (0.4 mM) and fixed at 14 days and scored for colonies containing at least 50 cells. (c) 0.5610 5 Hela-ATF3-1 inducible cells were placed in 100 cm dishes and grown in DMEM medium containing 2 mg/ml tetracycline for 16 h. Upon the withdrawal of tetracycline, cells were counted each day, in total 9 days ATF3 plays a negative role in cell cycle progression F Fan et al contrast, UV-or MMS-induction of ATF3 does not require p53 function. After DNA damage, ATF3 induction is rapid, transient, dose-dependent and through a transcriptional mechanism. The ATF3 promoter is activated by UV and MMS, but not by IR. In addition, the ATF3 promoter is also activated following expression of MEKK1, which is an upstream activator of ERK and JNK kinases. Through a 'tet-off system', inducible expression of ATF3 protein has been shown to slow down progression of cells from G1 to S phase and moderately suppresses cell growth. To a great extent, cellular response to DNA damaging agents initially includes induction of the genes that may have a role in the control of cell cycle progression, DNA repair and apoptosis. Many of DNA damage-inducible genes are transcription factors. However, gene induction, as a result of exposure to adverse conditions, is dependent on the nature of the stress. Oxidative stress, heat stress and DNA damage induce different sets of genes that are particular for each type of stress, but some of these genes can also be induced by more than one agent Holbrook et al., 1996) . The observations by others and our lab have demonstrated that ATF3 is induced by a variety of treatments, including both physiological stress signals and genotoxic stress agents. However, regulation of ATF3 after genotoxic stress is complex and may involve distinct signaling pathways. IRinduction of ATF3 requires normal p53 function because cells with deficient p53 do not exhibit induced ATF3 protein (Figure 1 and Table 1 ). In contrast, UV or MMS are able to induce expression of ATF3 protein in cells regardless of p53 status, indicating that UV-or MMS-induction of ATF3 protein is independent of cellular p53 function. In addition, the magnitude of cellular induction of ATF3 in response to non-IR stress appears variable because H1299 cells had little induction of ATF3 by UV compared to MMS treatment, indicating that multiple pathways regulate p53-independent response of ATF3, such as MAP kinase pathway or BRCA1-regulated pathway. Moreover, the varied magnitudes of ATF3 induction in wt p53 cells also suggest that cellular features in different cell lines other than p53 status may play an important role as well. The ATF3 promoter does not respond to the treatment with ionizing radiation and is not activated by p53. These results suggest the IRresponsive element(s), which might also be the p53-regulatory elements, is possibly located at the intronic region of the ATF3 gene. This might be similar to another p53-regulated gene, GADD45, in which the p53-regulatory element is found to localize at the third intron (Kastan et al., 1991) . In contrast, UV radiation and MMS, which are DNA base-damaging agents, can directly activate the ATF3 promoter, suggesting that UV-and MMS-responsive elements are located at the ATF3 promoter region. In addition, ATF3 promoter has been shown to be activated following expression of MEKK1, an upstream activator of JNK and ERK kinases, indicating that MAP kinase signaling pathways may well be involved in the induction of ATF3 protein in response to genotoxic stresses.
At the present time, the physiological consequences of ATF3 induction after genotoxic stress remain to be defined. Several lines of evidence indicate that ATF3 is involved in homeostasis, wound healing, metastasis and the signaling pathways mediating cellular response to genotoxic stress (Allen-Jennings et al., 2001; Hai and Hartman, 2001; Ishiguro and Nagawa, 2000; Wolfgang et al., 1997 Wolfgang et al., , 2000 . In addition, ATF3 is demonstrated to accelerate caspase protease activation during DNA damaging agentinduced apoptosis (Mashima et al., 2001) . Most recently, ATF3 was found to interact physically with p53 and disrupt the p53-mediated activation of the MMP2 gene, which plays a role in tumor metastases (Yan et al., 2002) . In this study, we have demonstrated that over-expression of ATF3 via tetracycline-inducible system in Hela cells moderately suppresses tumor cell growth (Figure 5b ). In agreement with this observa- a Hela ATF3-inducible cells were grown in DMEM medium with 10% fetal bovine serum in the presence of tetracycline at a concentration of 2 mg/ml. Upon withdrawal of tetracycline, nocodazol was added in culture medium. Cells were collected at the indicated time points and subject to flow cytometric analysis as described in Materials and methods. b Ratio of G1 population over G2-M population.
c Ratios of G1/G2-M in Hela ATF3-inducible cells that were cultured in the absence of tetracycline were compared to that of G1/G2-M in ATF3-inducible cells growing in medium containing tetracycline ATF3 plays a negative role in cell cycle progression F Fan et al tion, we have also noticed that the growth rates of isogenic cell lines expressing high levels of ATF3 proteins are slower compared to their parental lines (Figure 5c ). Interestingly, expression of ATF3 protein is shown to slow down the progression of Hela cells from G1 to S phase (Table 2 ). This might be part of the reason why ATF3 inhibits cell growth. With regard to the biochemical mechanism(s) by which ATF3 plays a negative role in cell cycle progression, the future investigation is required to understand whether ATF3 protein is directly involved in the control of cell cycle progression or through its transcriptional role in regulating cell cycle-related proteins.
Materials and methods

Cell lines, tissue culture
Human myeloid leukemia cells ML-1, lymphoma cells Molt4, lung carcinoma cells A549 were grown in DMEM medium containing 10% fetal bovine serum. The human colorectal carcinoma cells HCT116, human lung carcinoma cells H1299, human breast carcinoma cells MCF-7 were grown in F-12 medium supplemented with 10% fetal bovine serum (Zhan et al., 1994a (Zhan et al., , 1996 . Cells were maintained and irradiated with IR ( 137 Cs) at 5 Gy/min. For UV radiation, cells plated in 100 mm dishes were rinsed with PBS and irradiated with UVC to a dose of 10 Jm
72
. Following UV treatment, fresh medium was added in plates and cells were cultured in the incubator until harvest. For MMS treatment, cells were exposed to MMS (Aldrich) at 100 mg/ml for 4 h and then medium was replaced with fresh medium. Cells were then collected at the indicated time points (Zhan et al., 1996) .
Plasmid clones
pTRE-ATF3, a plasmid used for establishment of ATF3 inducible cell lines, was constructed by inserting ATF3 cDNA into BamHI/HindIII sites of pTRE plasmid (CLONTECH, Palo Alto, CA, USA). pATF3-CAT, ATF3 promoter CAT reporter construct, was provided by Dr Tsonwin Hai. pC53-SN3, a wild-type p53 expression vector and pC53-SCX3, which expresses a dominant-negative mutant p53 protein containing a substitution of Ala for Val-143, were provided by Dr Bert Volgestein (Kern et al., 1992) . pCMV-MEEK1 was provided by A Giaccia (Stanford University). pCR3-BRCA1, a construct expressing wt human BRCA1 protein, was provided by Dr Weber (Somasundaram et al., 1997) .
Transfection and CAT assay
Four mg of the ATF3 promoter reporter construct and 4 mg of indicated expression vectors were cotransfected into human HCT116 cells via the method of calcium phosphate precipitation. 40 h later, cells were collected for the CAT assay. In addition, 4 mg of pCMV-GFP plasmid (which contains green fluorescence protein) was included in each experiment. After transfection, expression of GFP protein is detected by Western blotting assay to determine transfection efficiency. Measurement of CAT activity was carried out as described previously (Zhan et al., 1993) . Cells were collected and resuspended in 0.25 M Tris (pH 7.8). Cells were disrupted by three cycles of freeze-thaw. The equal amounts of protein were used for each CAT assay. The CAT reaction mixture was incubated at 378C overnight and the CAT activity was determined by measuring the acetylation of 14 C-labeled chloramphenicol by thin-layer chromatography. The specific CAT activity was calculated by determining the fraction of chloramphenicol that had been acetylated. The relative CAT activity was determined by normalizing the activity of the treated samples to that of the untreated sample. Each value represented the average of at least three separate determinations Zhan et al., 1993) .
Antibodies, preparation of nuclear protein, immunoprecipitation and immunoblotting analysis Antibodies against ATF3 and actin were commercially provided by Santa Cruz Biotechnology (Santa Cruz Biotechnology, Santa Cruz, CA, USA). For preparation of nuclear protein, the exponentially growing HCT116 cells were collected, rinsed with PBS and resuspended in 200 ml of cold buffer A (10 mM HEPES pH 7.9; 10 mM KCl; 0.1 mM EDTA; 0.1 mM EGTA; 1 mM DTT; 0.5 mM PMSF). Following vortexing, the samples were incubated on ice for 10 min and followed by addition of NP-40 to a final 0.5% concentration. After centrifugation, insoluble pellets were resuspended in 100 ml ice-cold buffer C (20 mM HEPES pH 7.9; 400 mM KCl; 1 mM EDTA; 1 mM EGTA; 1 mM DTT; 1 mM PMSF). The samples were placed on ice and subject to vortexing for 15 s every 10 min, for total of 40 min. Finally, the samples were centrifuged at 14 000 g for 10 min and the supernatant (nuclear extract) was collected for further analysis. For immunoblotting analysis, 100 mg of proteins were loaded onto SDS -PAGE gel for electrophoresis and then transferred to Protran membranes. Membranes were blocked in 5% milk, washed with PBST (PBS with 0.1% Tween), and incubated with anti-ATF3 or actin antibodies (Santa Cruz Biotechnology). Following washing and incubation with HRP-conjugated anti-rabbit or anti-mouse antibody at 1 : 4000 in 5% milk, membranes were washed and detected by ECL (Amersham, Arlington Height, IL, USA) and exposed to X-ray film Zhan et al., 1998) .
RT -PCR
Total RNA was isolated using RNeasy Mini Kit (QIAGEN) according to the manufacture protocol. RT -PCR was done using RNA PCR Core Kit (Perkin Elmer). 0.5 mg of total RNA in 1 ml of RNase-free water was used in 20 ml of RT mix containing: 4 ml of 25 mM MgCl 2 , 2 ml of 106PCR Buffer, 2 ml of DEPC water, 8 ml of dNTP mix (2.5 mM each of dATP, dCTP, dGTP, dTTP), 1 ml of RNase Inhibitor (20 U/ml), 1 ml of Random Hexamers (50 mM), and 1 ml of MuLV Reverse Transcriptase (50 U/ml). The mixture was subjected to cDNA synthesis using GeneAmp PCR System 9600 (Perkin Elmer). Ten ml of cDNA product was added to 40 ml of PCR mix containing: 2 ml of 25 mM MgCl 2 , 4 ml of 106PCR Buffer, 3 ml of dNTP mix (2.5 mM each of dATP, dCTP, dGTP, dTTP), 28.5 ml of sterile distilled water, 0.5 ml of Taq DNA Polymerase (5 U/ml) and 2 ml of 1 : 1 primer mix (30 mM each of upstream and downstream primer). The mixture was subjected to DNA amplification using GeneAmp PCR System 9600 (Perkin Elmer).
Finally, 30 ml of PCR products were loaded on 1% agarose gel for analysis. The primers used to amplify Oct-1, Gadd45 and b-actin were designed as following; ATF3:5'primer ATGATGCTTCAACACCCAGGC, 3'primer TTAGCT-CTGCAATGTTCCTTC; Gadd45:5'primer GGAATTCCA-TATGGGGCGACCTGCAGTTTGC, 3'primer TAGCGCA-CATATGCAATTTGGTTCAGTTATT; b-Actin: 5'primer GCGGGAAATCGTGCGTGACATT; 5'-ATGATGCTTCA-ACACCCAGGC (cDNA position: 165 -185), 5'-TTAGCTC-TGCAATGTTCCTTC (cDNA position: 690 -710).
Growth suppression assay
Five hundred, 1000, or 2000 cells from Hela or HCT116 ATF3-inducble lines were seeded in 100 cm dishes and grown in DMEM medium containing 2 mg/ml tetracycline for 16 hours. Following withdrawal of tetracycline, cells were fixed at 14 days and scored for colonies containing at least 50 cells. In some cases, the therapeutic agents, cis-platinum and etopside were added at the indicated concentration. In addition, cellular protein was collected and analysed for ATF3 expression to ensure ATF3 was induced after removal of tetracycline Zhan et al., 1994c) .
Flow cytometric analysis
Hela ATF3-inducible cells were growing in DMEM medium with 10% fetal bovim serum in the presence of tetracycline at a concentration of 2 mg/ml. Upon withdrawal of tetracycline, nocodazol was added to the culture medium. Cells were collected at the indicated time points and washed in buffered saline, fixed in ice-cold 75% ethanol, and stored at 48C. Cells were then washed with buffered saline, treated with RNase A (500 units/ml) at 37 8 C for 15 min, and finally stained with propidium iodide (50 mg/ml) for 20 min. Cells cycle analysis was performed using a Becton-Dickinson fluorescenceactivated cell analyser, and DNA content was used to distinguish cell cycle phase; 10 000 cells for each point were analysed. Quantitation was performed using the CELL-QUEST and MODFIT LT software. Experiments were repeated at least three times Zhan et al., 1996) .
